Your browser doesn't support javascript.
loading
Feasibility outcomes of a randomised, multicentre, pilot trial comparing standard 6-monthly dosing of adjuvant zoledronate with a single one-time dose in patients with early stage breast cancer.
Awan, Arif; Ng, Terry; Conter, Henry; Raskin, William; Stober, Carol; Simos, Demetrios; Pond, Greg; Dhesy-Thind, Sukhbinder; Mates, Mihaela; Kumar, Vikaash; Fergusson, Dean; Hutton, Brian; Saunders, Deanna; Vandermeer, Lisa; Clemons, Mark.
Afiliación
  • Awan A; Department of Medicine, Division of Medical Oncology, The Ottawa Hospital and University of Ottawa, Ottawa, Canada.
  • Ng T; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, Canada.
  • Conter H; Department of Medicine, Division of Medical Oncology, The Ottawa Hospital and University of Ottawa, Ottawa, Canada.
  • Raskin W; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, Canada.
  • Stober C; William Osler Cancer Centre and Department of Oncology, University of Western Ontario, Brampton, Canada.
  • Simos D; William Osler Cancer Centre and Department of Oncology, University of Western Ontario, Brampton, Canada.
  • Pond G; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, Canada.
  • Dhesy-Thind S; Stronach Regional Cancer Center, Newmarket, Canada.
  • Mates M; Department of Oncology, Juravinski Hospital and Cancer Centre and McMaster University, Hamilton, Canada.
  • Kumar V; Department of Oncology, Juravinski Hospital and Cancer Centre and McMaster University, Hamilton, Canada.
  • Fergusson D; Cancer Centre of Southeastern Ontario, Kingston, Canada.
  • Hutton B; Markham Stouffville Hospital, Shakir Rehmatullah Cancer Clinic, Markham, Canada.
  • Saunders D; Clinical Epidemiology Program, The Ottawa Hospital Research Institute and University of Ottawa, Ottawa, Canada.
  • Vandermeer L; Clinical Epidemiology Program, The Ottawa Hospital Research Institute and University of Ottawa, Ottawa, Canada.
  • Clemons M; Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, Canada.
J Bone Oncol ; 26: 100343, 2021 Feb.
Article en En | MEDLINE | ID: mdl-33425673
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: J Bone Oncol Año: 2021 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: J Bone Oncol Año: 2021 Tipo del documento: Article País de afiliación: Canadá